Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Langton

Showing results (61-70 of 70) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 70 results.
The Lancet. Respiratory Medicine|October 1, 2021
Long-term safety and efficacy of dupilumab in patients with moderate-to-severe asthma (TRAVERSE): an open-label extension studyMichael E Wechsler, Linda B Ford, Jorge F Maspero, et al.
International Journal of Environmental Research and Public Health|June 24, 2022
'Breathing Fire': Impact of Prolonged Bushfire Smoke Exposure in People with Severe AsthmaTesfalidet Beyene, Erin S Harvey, Joseph Van Buskirk, et al.
The Journal of Allergy and Clinical Immunology. in Practice|June 17, 2023
Impact of Landscape Fire Smoke Exposure on Patients With Asthma With or Without Laryngeal HypersensitivityAnne E Vertigan, Erin S Harvey, Tesfalidet Beyene, et al.
JTO Clinical and Research Reports|April 20, 2026
Impacts of Multidisciplinary Lung Cancer Meeting Presentation in a Clinical Quality RegistryRob G Stirling, Sanuki Tissera, Jessie Zeng, et al.
Allergy|August 26, 2023
Biologics (mepolizumab and omalizumab) induced remission in severe asthma patientsDennis Thomas, Vanessa M McDonald, Sean Stevens, et al.
The Medical Journal of Australia|June 28, 2026
Treatment and Survival Outcomes for Indigenous and Non-Indigenous Australians Within the Victorian Lung Cancer Registry: A Retrospective Cross-Sectional Cohort StudyMelanie Wong, Mike Lloyd, Jessie Zeng, et al.
The Journal of Allergy and Clinical Immunology. in Practice|February 5, 2021
Mepolizumab and Oral Corticosteroid Stewardship: Data from the Australian Mepolizumab RegistryDennis Thomas, Erin S Harvey, Vanessa M McDonald, et al.
Respirology (Carlton, Vic.)|September 20, 2018
Treatable traits can be identified in a severe asthma registry and predict future exacerbationsVanessa M McDonald, Sarah A Hiles, Krystelle Godbout, et al.
The Lancet. Planetary Health|June 9, 2018
The Melbourne epidemic thunderstorm asthma event 2016: an investigation of environmental triggers, effect on health services, and patient risk factorsFrancis Thien, Paul J Beggs, Danny Csutoros, et al.
The New England Journal of Medicine|September 8, 2010
Icatibant, a new bradykinin-receptor antagonist, in hereditary angioedemaMarco Cicardi, Aleena Banerji, Francisco Bracho, et al.
Pageof 7

Showing results (61-70 of 70) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 70 results.
The Lancet. Respiratory Medicine|October 1, 2021
Long-term safety and efficacy of dupilumab in patients with moderate-to-severe asthma (TRAVERSE): an open-label extension studyMichael E Wechsler, Linda B Ford, Jorge F Maspero, et al.
International Journal of Environmental Research and Public Health|June 24, 2022
'Breathing Fire': Impact of Prolonged Bushfire Smoke Exposure in People with Severe AsthmaTesfalidet Beyene, Erin S Harvey, Joseph Van Buskirk, et al.
The Journal of Allergy and Clinical Immunology. in Practice|June 17, 2023
Impact of Landscape Fire Smoke Exposure on Patients With Asthma With or Without Laryngeal HypersensitivityAnne E Vertigan, Erin S Harvey, Tesfalidet Beyene, et al.
JTO Clinical and Research Reports|April 20, 2026
Impacts of Multidisciplinary Lung Cancer Meeting Presentation in a Clinical Quality RegistryRob G Stirling, Sanuki Tissera, Jessie Zeng, et al.
Allergy|August 26, 2023
Biologics (mepolizumab and omalizumab) induced remission in severe asthma patientsDennis Thomas, Vanessa M McDonald, Sean Stevens, et al.
The Medical Journal of Australia|June 28, 2026
Treatment and Survival Outcomes for Indigenous and Non-Indigenous Australians Within the Victorian Lung Cancer Registry: A Retrospective Cross-Sectional Cohort StudyMelanie Wong, Mike Lloyd, Jessie Zeng, et al.
The Journal of Allergy and Clinical Immunology. in Practice|February 5, 2021
Mepolizumab and Oral Corticosteroid Stewardship: Data from the Australian Mepolizumab RegistryDennis Thomas, Erin S Harvey, Vanessa M McDonald, et al.
Respirology (Carlton, Vic.)|September 20, 2018
Treatable traits can be identified in a severe asthma registry and predict future exacerbationsVanessa M McDonald, Sarah A Hiles, Krystelle Godbout, et al.
The Lancet. Planetary Health|June 9, 2018
The Melbourne epidemic thunderstorm asthma event 2016: an investigation of environmental triggers, effect on health services, and patient risk factorsFrancis Thien, Paul J Beggs, Danny Csutoros, et al.
The New England Journal of Medicine|September 8, 2010
Icatibant, a new bradykinin-receptor antagonist, in hereditary angioedemaMarco Cicardi, Aleena Banerji, Francisco Bracho, et al.
Pageof 7